Repository Corticotropin has 31 known drug interactions based on U.S. FDA drug labeling data. 8 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Amphotericin B, Chlorothiazide, Chlorothiazide Sodium. Patients taking Repository Corticotropin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 31
- Major
- 8
- Moderate
- 23
Major (8)
- Repository Corticotropin + Amphotericin B— May potentiate amphotericin B-induced hypokalemia, predisposing to cardiac dysfunction. Avoid concomitant use unless nec…
- Repository Corticotropin + Chlorothiazide— Intensified electrolyte depletion, particularly hypokalemia, may occur with concurrent use of ACTH and chlorothiazide.
- Repository Corticotropin + Chlorothiazide Sodium— Intensified electrolyte depletion, particularly hypokalemia, may occur when ACTH is given with chlorothiazide sodium.
- Repository Corticotropin + Hydrochlorothiazide— Intensified electrolyte depletion, particularly hypokalemia may occur.
- Repository Corticotropin + Sodium Chloride— Corticotropin is associated with sodium and fluid retention; concurrent use with sodium chloride injection may increase …
- Repository Corticotropin + Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride And Magnesium Chloride— Corticotropin causes sodium and fluid retention; concomitant use may increase risk of hypernatremia and volume overload.
- Repository Corticotropin + Sodium Chloride, Sodium Lactate, Potassium Chloride, Calcium Chloride And Dextrose Monohydrate— Avoid concomitant use due to increased risk of hypernatremia and volume overload. If unavoidable, closely monitor serum …
- Repository Corticotropin + Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate— Concurrent use with sodium phosphate may result in hypernatremia.
Moderate (23)
- Repository Corticotropin + Acetylsalicylic Acid— Aspirin should be used cautiously in conjunction with corticotropin in patients with hypoprothrombinemia.
- Repository Corticotropin + Amiloride Hydrochloride And Hydrochlorothiazide— Intensified electrolyte depletion, particularly hypokalemia, may occur when used concurrently with hydrochlorothiazide.
- Repository Corticotropin + Amphotericin B Liposome— Concurrent use may potentiate hypokalemia, which could predispose patient to cardiac dysfunction. Serum electrolytes and…
- Repository Corticotropin + Dextrose— Caution must be exercised when administering 70% Dextrose Injection USP to patients receiving corticotropin.
- Repository Corticotropin + Diuretics— Acthar Gel may accentuate the electrolyte loss associated with diuretic therapy.
- Repository Corticotropin + Hyaluronidase— Large doses of ACTH may require larger amounts of hyaluronidase for equivalent dispersing effect; these drugs render tis…
- Repository Corticotropin + Hyaluronidase, Ovine— Large doses may require larger amounts of hyaluronidase for equivalent dispersing effect; tissues become partly resistan…
- Repository Corticotropin + Irbesartan And Hydrochlorothiazide— Intensified electrolyte depletion, particularly hypokalemia.
- Repository Corticotropin + Metolazone— May increase risk of hypokalemia and increase salt and water retention.
- Repository Corticotropin + Metoprolol Tartrate And Hydrochlorothiazide— Concomitant use of ACTH with hydrochlorothiazide may cause hypokalemia, which can sensitize the heart to toxic effects o…
- Repository Corticotropin + Pantoprazole Sodium In 0.9% Sodium Chloride— Caution must be exercised in the administration of Sodium Chloride Injection to patients receiving corticotropin due to …
- Repository Corticotropin + Potassium Chloride And Sodium Chloride— May increase risk of hypernatremia and volume overload. Monitor serum electrolytes, fluid balance, and acid-base balance…
- Repository Corticotropin + Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous— Concurrent use with sodium phosphate may result in hypernatremia.
- Repository Corticotropin + Sodium Chloride, Calcium Chloride, And Potassium Chloride— Concomitant use may increase risk of hypernatremia and volume overload. Avoid use; if unavoidable, monitor serum electro…
- Repository Corticotropin + Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, Magnesium Chloride, Sodium Phosphate, Dibasic, And Potassium Phosphate— Sodium-containing solutions should be administered with caution to patients receiving corticotropin due to salt retentio…
- Repository Corticotropin + Sodium Lactate, Potassium Chloride, Magnesium Chloride, Monobasic Potassium Phosphate, Sodium Chloride And Dextrose Monohydrate— Concomitant use may increase risk of hypernatremia and volume overload. Monitor serum electrolytes, fluid balance and ac…
- Repository Corticotropin + Spironolactone— Intensified electrolyte depletion, particularly hypokalemia, may occur.
- Repository Corticotropin + Spironolactone And Hydrochlorothiazide— Intensified electrolyte depletion, particularly hypokalemia, may occur.
- Repository Corticotropin + Testosterone— Concurrent use with testosterone may result in increased fluid retention. Use with caution, particularly in patients wit…
- Repository Corticotropin + Testosterone Enanthate— Enhanced tendency toward edema; use caution, especially in patients with hepatic or cardiac disease.
- Repository Corticotropin + Testosterone Gel, 1%— Concurrent use with testosterone may result in increased fluid retention. Use with caution, particularly in patients wit…
- Repository Corticotropin + Torsemide— Increased risk of hypokalemia when used concomitantly with torsemide.
- Repository Corticotropin + Triamterene And Hydrochlorothiazide— Concurrent use with hydrochlorothiazide may intensify electrolyte imbalance, particularly hypokalemia, though triamteren…